Mohammad Saadatnia Selected Research

Intracranial Sinus Thrombosis (Sinus Thrombosis)

6/2015	Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study.
1/2015	Low levels of tissue factor pathway inhibitor increase the risk of cerebral venous thrombosis.
1/2013	Soluble thrombomodulin and endothelial cell protein C receptor levels in patients with cerebral venous and sinus thrombosis.
4/2012	Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis.
10/2009	The effect of fasting on cerebral venous and dural sinus thrombosis.
7/2008	Cerebral venous sinus thrombosis following tamoxifen prescription.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammad Saadatnia Research Topics

Disease

17	Stroke (Strokes) 11/2022 - 04/2007
7	Ischemic Stroke 01/2020 - 04/2007
6	Migraine Disorders (Migraine) 01/2022 - 01/2012
6	Intracranial Sinus Thrombosis (Sinus Thrombosis) 06/2015 - 07/2008
5	Headache (Headaches) 01/2022 - 01/2012
3	Infections 01/2022 - 11/2004
3	COVID-19 01/2022 - 01/2021
3	Infarction (Infarctions) 01/2022 - 01/2017
3	Hypertension (High Blood Pressure) 06/2021 - 11/2012
3	Multiple Sclerosis 05/2012 - 12/2011
2	Anemia 10/2019 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2018 - 09/2017
2	Thrombosis (Thrombus) 01/2017 - 01/2013
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2015 - 01/2012
2	Atherosclerosis 04/2014 - 01/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014 - 01/2010
1	Secondary Headache Disorders 01/2022
1	Transverse Myelitis (Necrotizing Myelitis) 11/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	ST Elevation Myocardial Infarction 09/2017
1	Acute Coronary Syndrome 09/2017
1	Atrial Fibrillation 09/2017
1	Congenital Heart Defects (Congenital Heart Defect) 09/2017
1	Heart Failure 09/2017
1	Drug Resistant Epilepsy 04/2017
1	Papilledema 01/2017
1	Brain Ischemia (Cerebral Ischemia) 01/2017
1	Cerebral Infarction 01/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2016
1	Inflammation (Inflammations) 01/2016
1	Thromboembolism 06/2015
1	Coronary Disease (Coronary Heart Disease) 01/2015
1	Thrombophilia 01/2014
1	Epilepsy (Aura) 03/2013
1	Migraine with Aura (Familial Hemiplegic Migraine) 03/2013
1	Protein S Deficiency (Deficiency, Protein S) 01/2013
1	Migraine without Aura (Common Migraine) 01/2013

Drug/Important Bio-Agent (IBA)

7	Oral ContraceptivesIBA 06/2021 - 11/2004
3	factor V LeidenIBA 01/2017 - 01/2014
3	hydroxide ionIBA 01/2017 - 04/2007
2	AntioxidantsIBA 06/2020 - 01/2017
2	Vitamin D FDA LinkGeneric 01/2017 - 01/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 01/2012
2	Prothrombin (Factor II)IBA 06/2015 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2013 - 01/2010
2	Immunoglobulin G (IgG)IBA 01/2012 - 04/2007
1	PhytochemicalsIBA 11/2022
1	Local AnestheticsIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Triamcinolone (Aristocort)FDA Link 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Infliximab (Remicade)FDA Link 11/2021
1	CoagulantsIBA 06/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2020
1	danaparoid (Orgaran)FDA Link 01/2019
1	omega-Chloroacetophenone (Mace)IBA 02/2018
1	astaxanthine (astaxanthin)IBA 01/2017
1	LycopeneIBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	beta Carotene (Betacarotene)FDA Link 01/2017
1	Carotenoids (Carotene)IBA 01/2017
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017
1	LuteinIBA 01/2017
1	ZeaxanthinsIBA 01/2017
1	EnzymesIBA 01/2016
1	Cell Adhesion MoleculesIBA 01/2016
1	ImmunosorbentsIBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2016
1	factor V CambridgeIBA 06/2015
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 06/2015
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2015
1	Dietary Fats (Dietary Fat)IBA 01/2015
1	CarbohydratesIBA 01/2015
1	Combined Oral ContraceptivesIBA 04/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 03/2013
1	Phosphorus (Red Phosphorus)IBA 01/2013
1	Parathyroid Hormone (Parathormone)IBA 01/2013
1	Protein CIBA 01/2013
1	Endothelial Protein C ReceptorIBA 01/2013
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2013
1	ThrombomodulinIBA 01/2013
1	CalciumIBA 01/2013
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2013
1	activated protein C receptorIBA 01/2013
1	Enalapril FDA LinkGeneric 01/2013

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2012
2	Decompressive Craniectomy 01/2022 - 10/2011
1	Nerve Block (Nerve Blocks) 01/2022
1	Traditional Medicine (Folk Remedies) 06/2021
1	Thrombectomy 01/2021
1	Exercise Therapy (Therapy, Exercise) 01/2020
1	Secondary Prevention 01/2019
1	Percutaneous Coronary Intervention 09/2017
1	High-Protein Low-Carbohydrate Diet (Atkins Diet) 04/2017
1	Blood Transfusion (Blood Transfusions) 01/2017
1	Thrombolytic Therapy 01/2017
1	Dietary Approaches To Stop Hypertension 01/2015